Yes, it is back to the good old "long standing relationship"...

Yes, it is back to the good old "long standing relationship" with GSK again.
GSK had probably promoted Relenza very hard by sending potential clients a copy of GSK's court document praising Tamiflu and rubbishing Relenza!

Peter Cook and the BTA board steadfastly refused to settle for 2006 $100M, the best ever time to get on and sell Relenza; went on and burn in excess of $30M and then settle for $20M. This wonderful performance should justify the hundreds of thousands of free BTA shares issued to our wonderful management at zero exercise price days before they settle at $20M

Well done Peter Cook.